Currently, chitosan (CS), alginate (ALG), hyaluronic acid (HA), and Angelica sinensis polysaccharide (ASP) are among the most widely studied polysaccharide-based nanocarriers for IBD treatment, owing to their favorable biocompatibility and functionality ( Figure 3 )
however, its therapeutic effects eventually wear off and can even cause motor complications, such as fluctuations and dyskinesias
KCNQ1OT1 facilitates HCC progression, and its knockdown has been shown to induce apoptosis and reduce cell proliferation, migration and invasion [62]
This range accommodates the spectrum from first-time users to individuals who have built tolerance under medical supervision
64 KlicekR.SeverM.RadicB.DrmicD.KocmanI.ZoricicI.et al (2008)